Skip to content

Effect of Sage Juice Consumption on Mineral Absorption - 2nd trial

Effect of Sage Juice Consumption on Mineral Absorption 2nd trial - Effect of Sage Juice Consumption on Mineral Absorption 2nd trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000059409
Enrollment
20
Registered
2025-11-30
Start date
2025-10-21
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Adults

Interventions

Sponsors

Finess Co, Ltd.
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1) A person who does not suffer from any disease (2) Males between the ages of 20 and 60 (3) BMI less than 30 kg/m2 (4) Persons who give written voluntary consent to participate in the study (5) Who are able to drink seabuckthorn Juice on a continuous basis

Exclusion criteria

Exclusion criteria: (1) Those who are currently under medication for iron deficiency anemia (2) Those who are currently receiving medication for some disease. (3) Those who are consuming foods or health foods containing the active ingredients of the food under study. (4) Persons with serious diseases or psychiatric disorders of glucose metabolism, lipid metabolism, liver function, renal function, heart, circulatory system, respiratory system, endocrine system, immune system, nervous system and those with a history of such diseases (5) Persons with a history of abnormal laboratory values that would be considered problematic for study participation (6) Persons who have a disease under treatment or a history of a serious disease that required medication (7) Persons who may develop allergies related to the study (8) Subjects who are judged to be unsuitable as subjects based on the results of the lifestyle questionnaire (9) Subjects who are participating in other clinical studies at the time this study is initiated. (10) Persons who are judged by the investigator (or study administrator) to be unsuitable to participate in the study.

Design outcomes

Primary

MeasureTime frame
Urinary mineral (Fe, Ca, Mg, Na)discharge (creatinine corrected)

Secondary

MeasureTime frame
Blood ferritin, red blood cells, serum iron, serum zinc, serum copper, hematocrit, UIBC, TIBC, MCH, MCHC

Countries

Japan

Contacts

Public ContactShigenori Nibun

EAS inc. Clinical Trial Session

info@eas-ct.jp045-374-3392

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026